Cargando…
Physiologically based modelling of tranexamic acid pharmacokinetics following intravenous, intramuscular, sub-cutaneous and oral administration in healthy volunteers
BACKGROUND: : Tranexamic acid (TXA) is an antifibrinolytic drug that reduces surgical blood loss and death due to bleeding after trauma and post-partum haemorrhage. Treatment success is dependant on early intervention and rapid systemic exposure to TXA. The requirement for intravenous (IV) administr...
Autores principales: | Kane, Zoe, Picetti, Roberto, Wilby, Alison, Standing, Joseph F., Grassin-Delyle, Stanislas, Roberts, Ian, Shakur-Still, Haleema |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Science B.V
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8299544/ https://www.ncbi.nlm.nih.gov/pubmed/34087356 http://dx.doi.org/10.1016/j.ejps.2021.105893 |
Ejemplares similares
-
WOMAN-PharmacoTXA trial: Study protocol for a randomised controlled trial to assess the pharmacokinetics and pharmacodynamics of intramuscular, intravenous and oral administration of tranexamic acid in women giving birth by caesarean section
por: Arribas, Monica, et al.
Publicado: (2021) -
Alternative routes to intravenous tranexamic acid for postpartum hemorrhage: A systematic search and narrative review
por: Shakur‐Still, Haleema, et al.
Publicado: (2022) -
Clinical Validation of a Volumetric Absorptive Micro-Sampling Device for Pharmacokinetic Studies With Tranexamic Acid
por: Grassin-Delyle, Stanislas, et al.
Publicado: (2021) -
What concentration of tranexamic acid is needed to inhibit fibrinolysis? A systematic review of pharmacodynamics studies
por: Picetti, Roberto, et al.
Publicado: (2019) -
Tranexamic acid by the intramuscular or intravenous route for the prevention of postpartum haemorrhage in women at increased risk: a randomised placebo-controlled trial (I’M WOMAN)
por: Brenner, Amy, et al.
Publicado: (2023)